Brief: Dr Reddy’s Executive Says Aim To Launch Generic Semaglutide For Obesity In Next Few Months In India
21/03/2026 05:28
March 21 (Reuters) - DR REDDY’S EXEC- AIM TO LAUNCH GENERIC SEMAGLUTIDE FOR OBESITY IN NEXT FEW MONTHS IN INDIA DR REDDY’S EXEC- COLLABORATING WITH TWO OF INDIA’S LEADING COMPANIES TO TAKE OUR GENERIC SEMAGLUTIDE IN THEIR BRAND NAME DR REDDY’S EXEC- PLAN TO LAUNCH HIGHER DOSES OF GENERIC SEMAGLUTIDE Source text: [ID:] Further company coverage: [NOVOb.CO] ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Dr. Reddy's Laboratories
See all newsDr Reddy's rolls out new generic Ozempic brands to ease Obeda supply hit
Dr Reddy's beats quarterly profit estimate on India market lift (updated)
India's Dr Reddy's beats quarterly profit estimate
Brief: Dr. Reddy's Q2 Consol Net PAT 9.25 Billion Rupees
Dr Reddy's rolls out new generic Ozempic brands amid Obeda supply disruption